je.st
news
Judge halts Alzheimer's drug swap until July
2014-12-16 01:01:59| Biotech - Topix.net
A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug. U.S. District Judge Robert Sweet tells Dublin-based Actavis PLC to continue making the drug Namenda available through July, when generic alternatives become available.
Tags: july
drug
judge
swap
Category:Biotechnology and Pharmaceuticals